APA (7th ed.) Citation

L, F., Jr, A. L., A, C., CP, C., E, P., AJ, C., . . . A, B. (2025). Daratumumab plus lenalidomide maintenance in newly diagnosed multiple myeloma after transplant: AURIGA subgroup analyses. Blood cancer journal, 15(1), 154. https://doi.org/10.1038/s41408-025-01355-0

Chicago Style (17th ed.) Citation

L, Foster, et al. "Daratumumab Plus Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma After Transplant: AURIGA Subgroup Analyses." Blood Cancer Journal 15, no. 1 (2025): 154. https://doi.org/10.1038/s41408-025-01355-0.

MLA (9th ed.) Citation

L, Foster, et al. "Daratumumab Plus Lenalidomide Maintenance in Newly Diagnosed Multiple Myeloma After Transplant: AURIGA Subgroup Analyses." Blood Cancer Journal, vol. 15, no. 1, 2025, p. 154, https://doi.org/10.1038/s41408-025-01355-0.